STOCK TITAN

American Vanguard (NYSE: AVD) CHRO awarded options for 20,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

American Vanguard Corp CHRO Shirin Khosravi received a grant of options to buy 20,000 shares of common stock. These incentive stock options have an exercise price of $2.51 per share and relate to 20,000 underlying common shares.

The options vest in full on the third anniversary of the June 4, 2026 grant date and expire on the tenth anniversary, June 4, 2036. Following this award, Khosravi holds options to acquire 20,000 shares directly, reflecting a compensation-related equity grant rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Khosravi Shirin
Role CHRO
Type Security Shares Price Value
Grant/Award Option to Buy 20,000 $0.00 --
Holdings After Transaction: Option to Buy — 20,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Option grant size 20,000 options Incentive stock options granted on June 4, 2026
Exercise price $2.51 per share Strike price for the 20,000 stock options
Underlying shares 20,000 shares Common stock underlying the granted options
Options outstanding post-grant 20,000 options Total options held by CHRO after this transaction
Option expiration date June 4, 2036 Tenth anniversary of the grant date
incentive stock options financial
"These constitute incentive stock options that vest in their entirety on the third anniversary"
Incentive stock options are a type of employee stock option that gives eligible workers the right to buy company shares at a fixed price later on, often below future market value. They matter to investors because they align employee incentives with company performance, can dilute existing ownership when exercised, and create potential tax advantages for option holders if certain holding-time rules are met — think of them as a coupon to buy stock at today’s price with extra tax rules attached.
vest financial
"options that vest in their entirety on the third anniversary of the grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"expire on the tenth anniversary of the grant date"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
exercise price financial
"conversion or exercise price of 2.5100 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Khosravi Shirin

(Last)(First)(Middle)
15440 LAGUNA CANYON ROAD, SUITE 100

(Street)
IRVINE CALIFORNIA 92618

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AMERICAN VANGUARD CORP [ AVD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHRO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Buy$2.5106/04/2026A20,000(1)06/04/202906/04/2036Common Stock20,000$020,000D
Explanation of Responses:
1. These constitute incentive stock options that vest in their entirety on the third anniversary of the grant date and expire on the tenth anniversary of the grant date.
/s/ SHIRIN KHOSRAVI06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did AMERICAN VANGUARD CORP (AVD) disclose about CHRO Shirin Khosravi?

AMERICAN VANGUARD CORP reported that CHRO Shirin Khosravi received a grant of options to buy 20,000 shares of common stock. This award is part of her compensation and does not involve any open-market buying or selling of existing shares.

How many stock options did AVD’s CHRO receive and at what price?

Shirin Khosravi received options to buy 20,000 shares of AMERICAN VANGUARD CORP common stock at an exercise price of $2.51 per share. This strike price is the amount she would pay per share if she exercises the options.

When do Shirin Khosravi’s AVD stock options vest and expire?

The incentive stock options granted to Shirin Khosravi vest in their entirety on the third anniversary of the June 4, 2026 grant date. They expire on the tenth anniversary of that date, June 4, 2036, if not exercised earlier.

Are the AVD stock option transactions by the CHRO open-market trades?

No, the reported transaction is a grant of incentive stock options to the CHRO as compensation. It does not represent an open-market purchase or sale of AMERICAN VANGUARD CORP shares, but rather a derivative award giving future rights to acquire stock.

How many AVD shares can the CHRO acquire after this stock option grant?

Following this grant, the CHRO holds options to acquire 20,000 shares of AMERICAN VANGUARD CORP common stock. These options become exercisable after vesting and allow her to buy those shares at the fixed $2.51 exercise price per share.